Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
- DOI
- 10.1016/s0140-6736(15)00469-9
- Published
- 2016-01
- Container
- The Lancet
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-15-00469-9,
title = {Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data},
author = {Rasha Khatib and Martin McKee and Harry Shannon and Clara Chow and Sumathy Rangarajan and Koon Teo and Li Wei and Prem Mony and Viswanathan Mohan and Rajeev Gupta and Rajesh Kumar and Krishnapillai Vijayakumar and Scott A Lear and Rafael Diaz and Alvaro Avezum and Patricio Lopez-Jaramillo and Fernando Lanas and Khalid Yusoff and Noorhassim Ismail and Khawar Kazmi and Omar Rahman and Annika Rosengren and Nahed Monsef and Roya Kelishadi and Annamarie Kruger and Thandi Puoane and Andrzej Szuba and Jephat Chifamba and Ahmet Temizhan and Gilles Dagenais and Amiram Gafni and Salim Yusuf},
year = {2016},
journal = {The Lancet},
doi = {10.1016/s0140-6736(15)00469-9},
url = {https://doi.org/10.1016/s0140-6736(15)00469-9}
}RIS
TY - JOUR TI - Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data AU - Rasha Khatib AU - Martin McKee AU - Harry Shannon AU - Clara Chow AU - Sumathy Rangarajan AU - Koon Teo AU - Li Wei AU - Prem Mony AU - Viswanathan Mohan AU - Rajeev Gupta AU - Rajesh Kumar AU - Krishnapillai Vijayakumar AU - Scott A Lear AU - Rafael Diaz AU - Alvaro Avezum AU - Patricio Lopez-Jaramillo AU - Fernando Lanas AU - Khalid Yusoff AU - Noorhassim Ismail AU - Khawar Kazmi AU - Omar Rahman AU - Annika Rosengren AU - Nahed Monsef AU - Roya Kelishadi AU - Annamarie Kruger AU - Thandi Puoane AU - Andrzej Szuba AU - Jephat Chifamba AU - Ahmet Temizhan AU - Gilles Dagenais AU - Amiram Gafni AU - Salim Yusuf PY - 2016 JO - The Lancet DO - 10.1016/s0140-6736(15)00469-9 UR - https://doi.org/10.1016/s0140-6736(15)00469-9 ER -
APA
Khatib, R., McKee, M., Shannon, H., Chow, C., Rangarajan, S., Teo, K., Wei, L., Mony, P., Mohan, V., Gupta, R., Kumar, R., Vijayakumar, K., Lear, S. A., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., Yusoff, K., Ismail, N., Kazmi, K., Rahman, O., Rosengren, A., Monsef, N., Kelishadi, R., Kruger, A., Puoane, T., Szuba, A., Chifamba, J., Temizhan, A., Dagenais, G., Gafni, A., & Yusuf, S. (2016). Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet. https://doi.org/10.1016/s0140-6736(15)00469-9
Source records
- crossref · retrieved 2026-09-26T22:45:03.824Z